Bill
SB 5201
SB 5201 establishes Washington State framework for regulated psychedelic substance access, balancing medical opportunity with safety oversight and federal law compliance concerns.
SB 5201 addresses access to psychedelic substances in Washington State, though the bill text itself is not provided in your summary. Based on the committee referrals to both Health & Long-Term Care and Labor & Commerce, the bill likely creates a framework for regulated access to psychedelics—possibly for therapeutic, medical, or research purposes. The bill has bipartisan sponsorship and has progressed through initial committee processes.
Psychedelic-assisted therapy is emerging as a potential treatment for conditions like PTSD, depression, and end-of-life anxiety, with some clinical evidence supporting efficacy. State-level legislation on this topic could establish regulatory pathways that either expand therapeutic options for patients or create legal clarity for medical providers and researchers. This represents a significant shift in drug policy and medical practice at the state level.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
